Showing 1250 – 1260 of 1295 results
-
ON24, Inc. Initiation
William Blair & Company initiated research coverage of ON24, Inc. (ONTF $55.26). ON24 is a digital experience platform that enables businesses to run interactive webinars and virtual event experiences with a focus on driving customer engagement and converting revenue.
-
908 Devices Inc Initiation
William Blair & Company initiated research coverage of 908 Devices Inc. (MASS $52.91). Boston-based 908 Devices delivers high-quality mass spectrometry to a broad set of users at the point of need. The company does this through an innovative suite of purpose-built handheld and desktop mass spectrometry devices that are smaller and more accessible than conventional lab instruments.
-
Fstar Therapeutics Inc and Merus NV Initiation
William Blair initiated research coverage of F-star Therapeutics, Inc. (FSTX $10.37) and Merus N.V. (MRUS $23.00), which are developing immuno-oncology therapies in the evolving field of bispecific and multispecific antibodies.
-
Privia Health Group Inc Initiation
William Blair initiated research coverage of Privia Health Group, Inc. (PRVA $30.08), a technology-enabled care management organization. Privia works with more than 2,700 providers and helps manage more than 3 million patients under a wide variety of fee-for-service and value-based care delivery arrangements.
-
Vaccitech plc Initiation
William Blair initiated research coverage of Vaccitech plc (VACC $14.58). Vaccitech is a clinical-stage biotechnology company that develops immunotherapeutics by leveraging its proprietary chimpanzee adenovirus and Modified Vaccinia Ankara T-cell-inducing platform. Areas of focus include therapeutic and prophylactic programs in the infectious disease and oncology space.
-
Social Determinants of Health
In this episode of William Blair Thinking Presents, equity research analyst Ryan Daniels dives deep into the healthcare team’s Quarterly Healthcare Mosaic report, which focuses on “food as medicine,” an emerging area in addressing social determinants of health.
-
Behavioral Healthcare Robust Demand and Ripe for Innovation
Following the COVID-19 pandemic, the behavioral healthcare industry has experienced an unprecedented surge in the need for innovation, increased access to care, and demand for services.
-
Waystar Holding Corp Initiation
William Blair initiated research coverage of Waystar Holding Corp. (WAY $21.50), a leading provider of end-to-end revenue cycle management (RCM) software solutions, partnering with hospital systems and ambulatory care providers to drive superior RCM performance from patient financial clearance and price transparency all the way through final cash collections.
-
Skyward Specialty Insurance Group Inc Initiation
William Blair initiated research coverage of Skyward Specialty Insurance Group, Inc. (SKWD $37.21), a specialty insurance company that writes complex risks in underserved commercial markets.
-
Tenax Therapeutics Inc Initiation
William Blair initiated research coverage of Tenax Therapeutics, Inc. (TENX $3.45). Tenax is focused on pulmonary and cardiovascular diseases, including lead program levosimendan for the treatment of pulmonary hypertension in patients with heart failure with preserved ejection fraction (PH-HFpEF).